SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer Robert B. LivingstonWilliam E. BarlowJoseph J. Kash • Kathy S. AlbainJulie R. GralowDanika L. Lew • Lawrence E. FlahertyMelanie E. RoyceGabriel N. Hortobagyi
Year: 2011
Type: article
Study design: Clinical Trial
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2340357828